Teva Pharmaceuticals USA recalls
Every recall we track for Teva Pharmaceuticals USA — 196 in all, from 2013–2022 — plus the complaints and injury reports the public filed about them. 25 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Teva Pharmaceuticals USA peaked in 2021 (56); 142 since 2017. 15% rated “stop using now”.
All FDA recall records for Teva Pharmaceuticals USA since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 1 | 0 | 10 | 6 | 17 |
| 2018 | 7 | 1 | 9 | 21 | 38 |
| 2019 | 0 | 1 | 1 | 3 | 5 |
| 2020 | 0 | 0 | 21 | 1 | 22 |
| 2021 | 13 | 5 | 17 | 21 | 56 |
| 2022 | 0 | 0 | 4 | 0 | 4 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
Teva Pharmaceuticals USA recalls before 2017
Recalls on record by year.
Most common reasons for Teva Pharmaceuticals USA recalls
What to do if you have a recalled Teva Pharmaceuticals USA product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Teva Pharmaceuticals USA recalls
60 shown- Lower riskDrug
Teva Pharmaceuticals USA recalls Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only,
Teva Pharmaceuticals USA recalls 100-count doxylamine succinate/pyridoxine hydrochloride tablets due to failed dissolution specification. This may affect medication effectiveness. Check NDC 0591-2132-01 and lots 100025842, 100028023.
Teva Pharmaceuticals USAJan 18, 2022 - Lower riskDrug
Teva Pharmaceuticals USA recalls Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC
Teva Pharmaceuticals recalls 100-count Tretinoin Capsules (10mg) due to failed dissolution testing. This may affect medication effectiveness. Contact Teva for details.
Teva PharmaceuticalsJan 10, 2022 - Lower riskDrug
Teva Pharmaceuticals USA recalls Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only,
Teva Pharmaceuticals USA recalls Mimvey (estradiol and norethindrone acetate) 1 mg/0.5 mg tablets due to mislabeling. Affected lots expire 03/2022 to 01/2023. No remedy specified in recall notice.
Teva PharmaceuticalsJan 7, 2022 - UnratedDrug
Teva Pharmaceuticals USA recalls MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only,
Teva Pharmaceuticals USA recalls 10mL multiple-dose vials of Methylprednisolone Acetate Injectable Suspension due to lack of sterility assurance. This could lead to infections if used improperly.
Teva Pharmaceuticals USADec 31, 2021 - Lower riskDrug
Teva Pharmaceuticals USA recalls Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL
Teva Pharmaceuticals USA recalls Penicillin V Potassium oral solution (125 mg/5mL) due to subpotent potency. This may result in less effective treatment for infections. Affected lots and expiration dates listed.
Teva Pharmaceuticals USADec 16, 2021 - Lower riskDrug
Teva Pharmaceuticals USA recalls Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottles (NDC 0591-2127-79), and b) 15 ml
Teva Pharmaceuticals recalls Brinzolamide Ophthalmic Suspension 1% dropper bottles due to a cap notch that may break off and block the dropper, preventing product dispensing.
Teva PharmaceuticalsDec 8, 2021 - Lower riskDrug
Teva Pharmaceuticals USA recalls Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT
Teva Pharmaceuticals USA recalls Clon: 0.1 mg/day patches due to failed impurities/degradation specs. Rx only. Check NDC 0591-3508-04 and lot 1369117B.
Teva Pharmaceuticals USAOct 28, 2021 - Use cautionDrug
Teva Pharmaceuticals USA recalls Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a)
Teva Pharmaceuticals is recalling specific lots of Cartia XT 120 mg capsules because the label shows an incorrect expiration date. Check your bottle's lot number.
TevaOct 27, 2021 - Lower riskDrug
Teva Pharmaceuticals USA recalls AirDuo Digihaler 55/14 (fluticasone propionate 55 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva
Teva recalls AirDuo Digihaler 55/14 inhalers due to potential subpotent salmeterol levels. This may result in less effective treatment for asthma. Affected units have NDC 59310-111-06 and were manufactured in Ireland.
TevaSep 22, 2021 - UnratedDrug
Teva Pharmaceuticals USA recalls Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis
Teva Pharmaceuticals USA recalls 7.5mg cyclobenzaprine tablets due to potential microbial contamination in an excipient batch. Affected products have NDC 70199-014-01 or 1408822A, expiring 08/2023. No specific remedy is stated in the recall notice.
Teva Pharmaceuticals USAJul 29, 2021 - Lower riskDrug
Teva Pharmaceuticals USA recalls Epoprostenol Sodium for Injection, 1.5 mg/vial, 10 mL vials, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA
Teva Pharmaceuticals recalls Epoprostenol Sodium injection vials due to lack of sterility assurance. This drug, used for severe heart conditions, may cause infections if not properly sterile.
Teva PharmaceuticalsJul 29, 2021 - Use cautionDrug
Teva Pharmaceuticals USA recalls Topotecan Injection 4 mg/4mL (1 mg/mL), Single-Dose vial, Teva Pharmaceuticals USA, Inc. North Whales, PA 19454, Carton
Teva Pharmaceuticals recalls Topotecan Injection vials with glass particles that could cause serious injury during infusion. Affected lots expire April 2022.
Teva PharmaceuticalsJun 18, 2021 - Use cautionDrug
Teva Pharmaceuticals USA recalls Haloperidol Decanoate Injection, USP 50 mg/mL, 1 mL Single Dose Vials, Rx Only, Sterile, 10 Vials, Teva
Teva recalls 10-vial Haloperidol Decanoate injection due to potential lack of sterility. This could cause infections if used improperly. Consumers should contact Teva for details.
TevaApr 26, 2021 - UnratedDrug
Teva Pharmaceuticals USA recalls Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Pharmaceuticals USA, Inc. NDC 0703-4004-01
Teva Pharmaceuticals recalls Romidepsin Injecton vials with impurity issues that may affect safety. Learn about affected lots and what to do.
Teva PharmaceuticalsMar 4, 2021 - Stop using nowDrug
Teva Pharmaceuticals USA recalls Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva
Teva recalls Metoclopramide injection vials with unknown brown residue inside. Consumers should check vial lot numbers and contact Teva for details.
TevaFeb 15, 2021 - UnratedDrug
Teva Pharmaceuticals USA recalls Epoprostenol Sodium for Injection, 1.5 mg/vial (1,500,000 ng), 10 mL vial, Rx only, Teva Pharmaceuticals USA, Inc.,
Teva Pharmaceuticals USA recalls Epoprostenol Sodium injection due to lack of sterility assurance. This sterile medication may contain harmful bacteria. Affected lots: 31326456B, exp. 02/28/2021.
Teva Pharmaceuticals USAFeb 10, 2021 - Lower riskDrug
Teva Pharmaceuticals USA recalls Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose
Teva Pharmaceuticals USA recalls Testosterone Gel 1% (2.5g units) due to high drug concentration in stability testing. This may cause unsafe levels of testosterone. Contact for details.
Teva Pharmaceuticals USANov 11, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis
Teva Pharmaceuticals USA recalls specific lots of Mesalamine Delayed-Release Tablets due to failed dissolution testing. Consumers should contact the company for details.
Teva Pharmaceuticals USAOct 28, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured
Teva Pharmaceuticals recalls Buprenorphine Transdermal Systems due to failed stability tests. The patches may not release medication properly, risking ineffective treatment. Check your carton number for affected lots.
Teva PharmaceuticalsSep 4, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle
Teva Pharmaceuticals USA recalls specific lots of Cephalexin oral suspension due to potential active ingredient levels outside specifications. Consumers should check their product details and contact the company for guidance.
Teva PharmaceuticalsAug 24, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake
Teva Pharmaceuticals USA recalls Lidocaine 5% patches with missing or incorrect lot/expiration dates on individual pouches. This labeling issue may lead to incorrect medication use. Consumers should check their patches for the lot and expiration date.
Teva Pharmaceuticals USAJul 14, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Metformin Hydrochloride Extended - Release Tablets, USP, 500 mg, a) 100 (NDC 62037-571-01) and b) 1,000 (NDC
Teva Pharmaceuticals USA recalls 500mg Metformin Hydrochloride Extended-Release Tablets due to N-Nitrosodimethylamine (NDMA) impurity exceeding safe levels. Affected products include specific NDC numbers and expiration dates.
Teva PharmaceuticalsJun 2, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed
Teva Pharmaceuticals USA recalls 5mg amphetamine tablets with possible mixed strengths. Consumers should check product details and contact the company for guidance.
Teva PharmaceuticalsMay 22, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls LOSARTAN POTASSIUM TABLETS, USP 50 mg, Bulk, Rx only, For Further Manufacturing, Packing or Repackaging only,
Teva Pharmaceuticals USA recalls 50mg losartan potassium tablets (NDC 0591-3746-00) manufactured in Malta with impurity NMBA detected in active ingredient. This is for further manufacturing, not for end consumers.
Teva Pharmaceuticals USAMar 25, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva
Teva recalls Epinephrine Injection USP 0.3 mg auto-injectors due to out-of-specification trigger force in a non-marketed lot. This may affect safety during use.
TevaMar 5, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL,
Teva Pharmaceuticals USA recalls 1.2g Mesalamine Delayed-Release Tablets due to failed dissolution testing. This may affect medication effectiveness. Check NDC 0591-2245-2: 120-count bottle, Rx only, manufactured by Actavis Laboratories.
Teva Pharmaceuticals USAFeb 20, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Tramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottles (NDC 0093-0058-01), b) 500-count
Teva Pharmaceuticals recalls 50mg tramadol tablets with incorrect patient instructions that may lead to improper dosing. Affected lots manufactured in Czech Republic for US distribution.
Teva PharmaceuticalsJan 28, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals
Teva recalls 27mg Methylphenidate extended-release tablets due to possible missing desiccant, which may cause moisture damage. This is a controlled substance prescription-only product.
Teva PharmaceuticalsJan 27, 2020 - Lower riskDrug
Teva Pharmaceuticals USA recalls Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort
Teva Pharmaceuticals USA recalls 0.1 mg Desmopressin Acetate Tablets due to possible missing desiccant, which may affect product stability. Affected lots expire 03/2020 and 04/2020.
Teva Pharmaceuticals USAJan 27, 2020 - UnratedDrug
Teva Pharmaceuticals USA recalls Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by:
Teva Pharmaceuticals USA recalls Matzim LA (Diltiaz: 240mg tablets due to a manufacturing deviation. This lot was not intended for commercial distribution. Consumers should contact the manufacturer for details.
Teva Pharmaceuticals USASep 6, 2019 - UnratedDrug
Teva Pharmaceuticals USA recalls LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00
Teva Pharmaceuticals USA recalls Losartan Potassium 50mg tablets due to impurity detected in active ingredient. Affected lots may pose health risks. Consumers should check product details and contact Teva for guidance.
TevaJun 6, 2019 - Use cautionDrug
Teva Pharmaceuticals USA recalls Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in (a) 150 mL bottle (NDC 0093-4150-80) (b) 80 mL bottle
Teva Pharmaceuticals USA recalls specific lots of Amoxicillin for Oral Suspension USP because assay results were below specification limits.
Teva PharmaceuticalsApr 12, 2019 - Lower riskDrug
Teva Pharmaceuticals USA recalls Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each),
Teva Pharmaceuticals USA recalls 15mg Lansoprazole Delayed-Release Orally Disintegrating Tablets (NDC 0093-3008-93) for subpotent drug content. This medication may not provide the intended treatment.
TevaMar 11, 2019 - Lower riskDrug
Teva Pharmaceuticals USA recalls Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56),
Teva Pharmaceuticals USA recalls 40mg/25mg Olmesartan Medoxomil and Hydrochlorothiazide tablets due to failed dissolution specifications. Affected lots expire February 2019.
Teva PharmaceuticalsDec 19, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Amlodipine and Valsartan Tablets 5 mg/160 mg, (a) 30-count bottles (NDC 0093-7690-56) & 90-count bottles (NDC
Teva recalls 5 mg/160 mg Amlodipine and Valsartan tablets due to FDA-confirmed NDEA impurity. Stop using affected bottles with specific NDC numbers.
TevaNov 27, 2018 - UnratedDrug
Teva Pharmaceuticals USA recalls Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis
Teva Pharmaceuticals USA recalls 50mg Metoprolol Succinate Extended Release Tablets due to failed dissolution test. No remedy specified in official notice.
Teva Pharmaceuticals USAOct 19, 2018 - Use cautionDrug
Teva Pharmaceuticals USA recalls Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals
Teva Pharmaceuticals recalls Alprostadil Injection USP 500 mcg/mL vials due to impurities detected in stability testing. This may cause serious injury if used improperly.
Teva PharmaceuticalsSep 27, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North
Teva Pharmaceuticals recalls 12.5mg Clozapine orally disintegrating tablets due to failed disintegration test. Rx-only medication with specific lot number and expiration date.
Teva PharmaceuticalsSep 21, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North
Teva Pharmaceuticals recalls 2mg Clonazepam orally disintegrating tablets due to water content failure in stability testing. This affects RX-only products with specific lot numbers.
Teva PharmaceuticalsSep 20, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Paliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-count bottle (NDC
Teva recalls 9mg Paliperidone Extended Release Tablets due to potential missing laser drilling affecting drug release. Rx only, 30-count and 90-count bottles with specific NDCs and expiration dates.
Teva Pharmaceuticals USAAug 6, 2018 - UnratedDrug
Teva Pharmaceuticals USA recalls Omega-3-Acid Ethyl Esters Capsules USP, 1 gram* 120-count bottle Rx Only. Manufactured by: Banner Pharmacaps, Inc. High
Teva Pharmaceuticals USA recalls 120-count Omega-3 capsules due to unapproved manufacturing materials. This may pose safety risks if taken without regulatory approval. Consumers should contact Teva for details.
Teva Pharmaceuticals USAJul 16, 2018 - UnratedDrug
Teva Pharmaceuticals USA recalls Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 160 mg/12.5 mg tablets, USP 90-count bottle, Rx Only, Rx Only,
Teva Pharmaceuticals USA recalls 90-count Valsartan/HCTZ tablets due to detected carcinogen impurity in manufacturing. This may pose cancer risk. Consumers should contact Teva for details.
Teva PharmaceuticalsJul 16, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL bottle, Rx Only, Manufactured by: Actavis Laboratories UT,
Teva recalls 0.01% Fluocinolone Acetonide Topical Solution 60mL bottles due to failed impurities and degradation tests. This may affect drug safety and efficacy. Contact Teva for details.
Teva PharmaceuticalsJul 5, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC
Teva Pharmaceuticals USA recalls Lidocaine 5% patches (NDC 0591-3525-11) due to failed stability specifications. Consumers should check product lot numbers and contact Teva for details.
Teva Pharmaceuticals USAApr 30, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC
Teva Pharmaceuticals USA recalls Estradiol Vaginal Inserts (10 mcg) due to difficulty dispensing tablets from the applicator. Affected lots and packaging details provided.
TevaMar 19, 2018 - Lower riskDrug
Teva Pharmaceuticals USA recalls Fluoxetine Tablets USP, 10 mg, 30-count bottle, Rx only, Manufactured in Israel by: Teva Pharmaceuticals IND, LTD,
Teva Pharmaceuticals USA recalls 10mg fluoxetine tablets due to impurities found in stability testing. Affected products may have unsafe levels of lactoside. Contact for return instructions.
Teva PharmaceuticalsFeb 5, 2018 - UnratedDrug
Teva Pharmaceuticals USA recalls Fentanyl Transdermal System. 25 mcg/h, packaged in 5 pouch system cartons (NDC 0591-3198-72), Rx Only, Manufactured by:
Teva recalls Fentanyl Transdermal System (25 mcg/h) due to potential Fentanyl-n-Oxide impurities exceeding safety limits. Rx-only product with specific lot numbers and expiration dates.
Teva Pharmaceuticals USAJan 29, 2018 - UnratedDrug
Teva Pharmaceuticals USA recalls Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP, 7.5 mg/12.5 mg, 100-count bottle, Rx only, Distributed
Teva recalls 7.5mg/12.5mg Moexipril-Hydrochlorothiazide tablets due to high impurity levels detected in stability testing. This may pose a risk to patients using prescription medication.
Teva PharmaceuticalsDec 14, 2017 - UnratedDrug
Teva Pharmaceuticals USA recalls Penicillin V Potassium for Oral Solution, USP, 125 mg (200,000 U) per 5 mL, 100 mL (when mixed) bottle, Rx only,
Teva Pharmaceuticals USA recalls Penicillin V Potassium oral solution due to high impurities. This medication, sold in 100mL bottles, may contain unsafe levels of impurities that could pose health risks. Consumers should contact the manufacturer for details.
TevaNov 28, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx
Teva recalls Amethyst birth control pills due to incorrect labeling that says some tablets are inactive when all are active. This could lead to unintended pregnancy if users skip doses.
Teva Pharmaceuticals USANov 20, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD,
Teva Pharmaceuticals USA recalls 100mg Clozapine tablets (500 count) due to potential broken tablets. Rx only; manufactured in Israel, lot 39C192, expires 06/2019.
TevaNov 9, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count
Teva Pharmaceuticals USA recalls Dutasteride and Tamsulosin HCl capsules due to failed dissolution tests. All lots within expiry are affected. No remedy specified in recall notice.
Teva Pharmaceuticals USAOct 25, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories,
Teva Pharmaceuticals USA recalls 20mg methylphenidate tablets due to failed dissolution testing. This may affect medication effectiveness. Contact for return instructions.
Teva PharmaceuticalsOct 17, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000,
Teva Pharmaceuticals USA recalls Acarbose Tablets 25mg 100-count bottles due to incorrect expiration date (July 2018) printed on labels instead of July 2017. This may lead to medication safety issues.
Teva Pharmaceuticals USASep 5, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx
Teva Pharmaceuticals USA recalls 5mg Glipizide Extended-Release Tablets due to failed moisture limits in stability testing. This may affect drug efficacy but does not pose immediate safety risks.
Teva Pharmaceuticals USAAug 2, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials
Teva Pharmaceuticals USA recalls Albuterol Sulfate Inhalation Solution with high impurities. Products may contain unsafe levels of related compound D. Check lot numbers for affected batches.
Teva Pharmaceuticals USAJul 25, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA
Teva Pharmaceuticals recalls 20mg Famotidine tablets due to weight specification failure. This may affect medication accuracy. Contact for details.
Teva PharmaceuticalsJul 24, 2017 - UnratedDrug
Teva Pharmaceuticals USA recalls Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bottle, Rx only, Distributed by: Teva
Teva Pharmaceuticals USA recalls specific lots of Buprenorphine and Naloxone sublingual tablets (2mg/0.5mg) due to failed impurities tests. These prescription-only products may contain unsafe levels of related compounds.
TevaJun 29, 2017 - Stop using nowDrug
Teva Pharmaceuticals USA recalls Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose
Teva Pharmaceuticals USA recalls specific Clozapine tablets due to microbial contamination. Affected products include 100-count and 500-count bottles with lot numbers 07C160 and 07C160A. Stop using immediately if you have these items.
TevaApr 24, 2017 - Lower riskDrug
Teva Pharmaceuticals USA recalls PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By:
Teva Pharmaceuticals USA recalls PrednisoLONE Oral Solution 15mg/5mL with alcohol content 5% due to failed stability specifications. This medication is prescription-only and may be unsafe if not stored properly.
Teva Pharmaceuticals USAMar 28, 2017
Teva Pharmaceuticals USA recall questions
How many recalls has Teva Pharmaceuticals USA had?
196 recalls from Teva Pharmaceuticals USA are on record with U.S. safety agencies, from 2013–2022.
What is the most recent Teva Pharmaceuticals USA recall?
Teva Pharmaceuticals USA recalls Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only,, dated Jan 18, 2022. Every Teva Pharmaceuticals USA recall is listed on this page, newest first.
Why are Teva Pharmaceuticals USA products recalled?
The most common reasons on record: Lack of Assurance of Sterility (26); Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol (5); Some bottles may contain mixed strengths of the product. (3); CGMP Deviations (2).
What should I do if I have a recalled Teva Pharmaceuticals USA product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Teva Pharmaceuticals USA recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.